0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lafutidine Tablets Market Research Report 2026
Published Date: 2026-03-04
|
Report Code: QYRE-Auto-24M17446
Home | Market Reports
Global Lafutidine Tablets Market Research Report 2024
BUY CHAPTERS

Global Lafutidine Tablets Market Research Report 2026

Code: QYRE-Auto-24M17446
Report
2026-03-04
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lafutidine Tablets Market

The global Lafutidine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lafutidine Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Lafutidine Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Lafutidine Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Lafutidine Tablets include Jiangsu Runbang Pharmaceutical Co., Ltd., Chengdu Hengrui Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd., Yuekang Pharmaceutical Group Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Lafutidine Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lafutidine Tablets. The Lafutidine Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lafutidine Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lafutidine Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Lafutidine Tablets Market Report

Report Metric Details
Report Name Lafutidine Tablets Market
Segment by Type
  • 10mg
  • 5mg
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jiangsu Runbang Pharmaceutical Co., Ltd., Chengdu Hengrui Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd., Yuekang Pharmaceutical Group Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Lafutidine Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Lafutidine Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Lafutidine Tablets Market report?

Ans: The main players in the Lafutidine Tablets Market are Jiangsu Runbang Pharmaceutical Co., Ltd., Chengdu Hengrui Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd., Yuekang Pharmaceutical Group Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Lafutidine Tablets Market report?

Ans: The Applications covered in the Lafutidine Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Lafutidine Tablets Market report?

Ans: The Types covered in the Lafutidine Tablets Market report are 10mg, 5mg

1 Lafutidine Tablets Market Overview
1.1 Product Definition
1.2 Lafutidine Tablets by Type
1.2.1 Global Lafutidine Tablets Market Value by Type: 2025 vs 2032
1.2.2 10mg
1.2.3 5mg
1.3 Lafutidine Tablets by Application
1.3.1 Global Lafutidine Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Lafutidine Tablets Market Size Estimates and Forecasts
1.4.1 Global Lafutidine Tablets Revenue 2021–2032
1.4.2 Global Lafutidine Tablets Sales 2021–2032
1.4.3 Global Lafutidine Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lafutidine Tablets Market Competition by Manufacturers
2.1 Global Lafutidine Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lafutidine Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lafutidine Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lafutidine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lafutidine Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lafutidine Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Lafutidine Tablets, Date of Entry into the Industry
2.8 Global Lafutidine Tablets Market Competitive Situation and Trends
2.8.1 Global Lafutidine Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lafutidine Tablets Players Market Share by Revenue
2.8.3 Global Lafutidine Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lafutidine Tablets Market Scenario by Region
3.1 Global Lafutidine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lafutidine Tablets Sales by Region: 2021–2032
3.2.1 Global Lafutidine Tablets Sales by Region: 2021–2026
3.2.2 Global Lafutidine Tablets Sales by Region: 2027–2032
3.3 Global Lafutidine Tablets Revenue by Region: 2021–2032
3.3.1 Global Lafutidine Tablets Revenue by Region: 2021–2026
3.3.2 Global Lafutidine Tablets Revenue by Region: 2027–2032
3.4 North America Lafutidine Tablets Market Facts & Figures by Country
3.4.1 North America Lafutidine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lafutidine Tablets Sales by Country (2021–2032)
3.4.3 North America Lafutidine Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lafutidine Tablets Market Facts & Figures by Country
3.5.1 Europe Lafutidine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lafutidine Tablets Sales by Country (2021–2032)
3.5.3 Europe Lafutidine Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lafutidine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Lafutidine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lafutidine Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Lafutidine Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lafutidine Tablets Market Facts & Figures by Country
3.7.1 Latin America Lafutidine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lafutidine Tablets Sales by Country (2021–2032)
3.7.3 Latin America Lafutidine Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lafutidine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Lafutidine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lafutidine Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lafutidine Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lafutidine Tablets Sales by Type (2021–2032)
4.1.1 Global Lafutidine Tablets Sales by Type (2021–2026)
4.1.2 Global Lafutidine Tablets Sales by Type (2027–2032)
4.1.3 Global Lafutidine Tablets Sales Market Share by Type (2021–2032)
4.2 Global Lafutidine Tablets Revenue by Type (2021–2032)
4.2.1 Global Lafutidine Tablets Revenue by Type (2021–2026)
4.2.2 Global Lafutidine Tablets Revenue by Type (2027–2032)
4.2.3 Global Lafutidine Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Lafutidine Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lafutidine Tablets Sales by Application (2021–2032)
5.1.1 Global Lafutidine Tablets Sales by Application (2021–2026)
5.1.2 Global Lafutidine Tablets Sales by Application (2027–2032)
5.1.3 Global Lafutidine Tablets Sales Market Share by Application (2021–2032)
5.2 Global Lafutidine Tablets Revenue by Application (2021–2032)
5.2.1 Global Lafutidine Tablets Revenue by Application (2021–2026)
5.2.2 Global Lafutidine Tablets Revenue by Application (2027–2032)
5.2.3 Global Lafutidine Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Lafutidine Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jiangsu Runbang Pharmaceutical Co., Ltd.
6.1.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
6.1.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.1.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Chengdu Hengrui Pharmaceutical Co., Ltd.
6.2.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
6.2.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.2.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Sichuan Kelun Pharmaceutical Co., Ltd.
6.3.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
6.3.2 Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.3.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Hubei Shubang Pharmaceutical Co., Ltd.
6.4.1 Hubei Shubang Pharmaceutical Co., Ltd. Company Information
6.4.2 Hubei Shubang Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.4.5 Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Yuekang Pharmaceutical Group Co., Ltd.
6.5.1 Yuekang Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Yuekang Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio
6.5.5 Yuekang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 China Resources Double Crane Pharmaceutical Co., Ltd.
6.6.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
6.6.2 China Resources Double Crane Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.6.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Shandong Qidu Pharmaceutical Co., Ltd.
6.7.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
6.7.2 Shandong Qidu Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
6.7.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lafutidine Tablets Industry Chain Analysis
7.2 Lafutidine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lafutidine Tablets Production Mode & Process Analysis
7.4 Lafutidine Tablets Sales and Marketing
7.4.1 Lafutidine Tablets Sales Channels
7.4.2 Lafutidine Tablets Distributors
7.5 Lafutidine Tablets Customer Analysis
8 Lafutidine Tablets Market Dynamics
8.1 Lafutidine Tablets Industry Trends
8.2 Lafutidine Tablets Market Drivers
8.3 Lafutidine Tablets Market Challenges
8.4 Lafutidine Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lafutidine Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Lafutidine Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Lafutidine Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Lafutidine Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Lafutidine Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Lafutidine Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Lafutidine Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Lafutidine Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Lafutidine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Lafutidine Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Lafutidine Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Lafutidine Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lafutidine Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lafutidine Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lafutidine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Lafutidine Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Lafutidine Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Lafutidine Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Lafutidine Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Lafutidine Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Lafutidine Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Lafutidine Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Lafutidine Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Lafutidine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Lafutidine Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Lafutidine Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Lafutidine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Lafutidine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Lafutidine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Lafutidine Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Lafutidine Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Lafutidine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Lafutidine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Lafutidine Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Lafutidine Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Lafutidine Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Lafutidine Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Lafutidine Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Lafutidine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Lafutidine Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Lafutidine Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Lafutidine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Lafutidine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Lafutidine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Lafutidine Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Lafutidine Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Lafutidine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Lafutidine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Lafutidine Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Lafutidine Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Lafutidine Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Lafutidine Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Lafutidine Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Lafutidine Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Lafutidine Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Lafutidine Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Lafutidine Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Lafutidine Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Lafutidine Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Lafutidine Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Lafutidine Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Lafutidine Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Lafutidine Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Lafutidine Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Lafutidine Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Lafutidine Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Lafutidine Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Lafutidine Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
 Table 71. Jiangsu Runbang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 74. Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
 Table 76. Chengdu Hengrui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 79. Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
 Table 81. Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 84. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Hubei Shubang Pharmaceutical Co., Ltd. Company Information
 Table 86. Hubei Shubang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 89. Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Yuekang Pharmaceutical Group Co., Ltd. Company Information
 Table 91. Yuekang Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 92. Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product
 Table 94. Yuekang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 95. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
 Table 96. China Resources Double Crane Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 99. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Shandong Qidu Pharmaceutical Co., Ltd. Company Information
 Table 101. Shandong Qidu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product
 Table 104. Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Lafutidine Tablets Distributors List
 Table 108. Lafutidine Tablets Customers List
 Table 109. Lafutidine Tablets Market Trends
 Table 110. Lafutidine Tablets Market Drivers
 Table 111. Lafutidine Tablets Market Challenges
 Table 112. Lafutidine Tablets Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lafutidine Tablets
 Figure 2. Global Lafutidine Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Lafutidine Tablets Market Share by Type: 2025 & 2032
 Figure 4. 10mg Product Picture
 Figure 5. 5mg Product Picture
 Figure 6. Global Lafutidine Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Lafutidine Tablets Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Lafutidine Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Lafutidine Tablets Market Size (US$ Million), 2021–2032
 Figure 13. Global Lafutidine Tablets Sales (K Units), 2021–2032
 Figure 14. Global Lafutidine Tablets Average Price (US$/Unit), 2021–2032
 Figure 15. Lafutidine Tablets Report Years Considered
 Figure 16. Lafutidine Tablets Sales Share by Manufacturers in 2025
 Figure 17. Global Lafutidine Tablets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Lafutidine Tablets Players: Market Share by Revenue in Lafutidine Tablets in 2025
 Figure 19. Lafutidine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Lafutidine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Lafutidine Tablets Sales Market Share by Country (2021–2032)
 Figure 22. North America Lafutidine Tablets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Lafutidine Tablets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Lafutidine Tablets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Lafutidine Tablets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Lafutidine Tablets Revenue Market Share by Region (2021–2032)
 Figure 34. China Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Lafutidine Tablets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Lafutidine Tablets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Lafutidine Tablets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Lafutidine Tablets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Lafutidine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Lafutidine Tablets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Lafutidine Tablets by Type (2021–2032)
 Figure 54. Global Lafutidine Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Lafutidine Tablets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Lafutidine Tablets by Application (2021–2032)
 Figure 57. Global Lafutidine Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 58. Lafutidine Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure